WPI (Raloxifene hydrochloride 60 mg)
Pill imprint WPI has been identified as Raloxifene hydrochloride 60 mg.
Raloxifene is used in the treatment of breast cancer, prevention; prevention of osteoporosis; osteoporosis and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. Not for use in pregnancy. Raloxifene 60 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WPI
- Strength:
- 60 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Hormones/antineoplastics
Selective estrogen receptor modulators - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Actavis Pharma, Inc.
More about raloxifene
Consumer resources
- Other brands: Evista
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
